Plants and human health in the twenty-first century

Trends in Biotechnology

Volumn 20, Issue 12, 2002, Pages 522-531

  Raskin, Ilya ^a   Ribnicky, David M ^a   Komarnytsky, Slavko ^a   Ilic, Nebojsa ^b   Poulev, Alexander ^b   Borisjuk, Nikolai ^a   Brinker, Anita ^a   Moreno, Diego A ^a   Ripoll, Christophe ^a   Yakoby, Nir ^a   O'Neal, Joseph M ^b   Cornwell, Teresa ^a   Pastor, Ira ^b   Fridlender, Bertold ^b  

^a RUTGERS UNIVERSITY   (United States)

^b Phytomedics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRICULTURE; CROPS; DIAGNOSIS; DISEASES; DRUG PRODUCTS; FIBERS; FOOD PRODUCTS; HEALTH; MEDICINE; PLANTS (BOTANY); PROTEINS;

PHYTOCHEMICALS;

BIOTECHNOLOGY;

ACETYLSALICYLIC ACID; ALKALOID DERIVATIVE; ARTEMISIN; ATROPINE; CAPSAICIN; CODEINE; COLCHICINE; DIGOXIN; DIOSGENIN; ECHINACEA EXTRACT; EMETINE; GALANTAMINE; GARLIC EXTRACT; HECOGENIN; HYOSCYAMINE; IPECAC; PACLITAXEL; PHYSOSTIGMINE; PODOPHYLLOTOXIN; QUININE; RECOMBINANT PROTEIN; RESERPINE; SENNOSIDE A; SENNOSIDE B; STIGMASTEROL; UNINDEXED DRUG; VEGETABLE PROTEIN; VINBLASTINE; VINCRISTINE; YOHIMBINE;

BIOTECHNOLOGY; MEDICINE; PLANT;

AGRICULTURE; BOTANY; CROP PRODUCTION; DIAGNOSTIC VALUE; DIET SUPPLEMENTATION; DRUG MANUFACTURE; HEALTH; MEDICINAL PLANT; NONHUMAN; PHYTOCHEMISTRY; PLANT BIOTECHNOLOGY; PLANT GROWTH; PRIORITY JOURNAL; REVIEW;

DIETARY SUPPLEMENTS; DRUGS, CHINESE HERBAL; FOOD, FORTIFIED; FOOD, GENETICALLY MODIFIED; FORECASTING; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, GENETICALLY MODIFIED; PLANTS, MEDICINAL; RECOMBINANT PROTEINS; TECHNOLOGY, PHARMACEUTICAL;

ALLIUM SATIVUM; CEPHAELIS IPECACUANHA; CINCHONA PUBESCENS;

EID: 6444244303     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(02)02080-2     Document Type: Review

References (79)

1. Swerdlow J. Nature's Medicine. Plants That Heal. 2000;National Geographic Society.
2. Pierpoint W.S. Salicylic acid and its derivatives in plants: Medicines, metabolites and messenger molecules. Adv. Bot. Res. 20:1994;163-235.
3. Business Communications Company, Inc . Plant-Derived Drugs: Products, Technologies and Applications. 1998;121 Study RB.
4. Farnsworth N.R. Screening plants for new medicines. Wilson E.O., Biodiversity. 1988;83-97 National Academy Press.
5. Cordell G.A. Biodiversity and drug discovery. A symbiotic relationship. Phytochemistry. 55:2000;463-480.
6. Newman D.J., et al. The influence of natural products upon drug discovery. Nat. Prod. Rep. 17:2000;215-234.
7. Farnsworth N.R., Morris R.W. Higher plants - the sleeping giant of drug development. Am. J. Pharm. Educ. 148:1976;46-52.
8. Rates S.M.K. Plants as sources of drugs. Toxicon. 39:2001;603-613.
9. Adang A.E., Hermkens P.H. The contribution of combinatorial approaches to lead generation: An interim analysis. Curr. Med. Chem. 8:2001;985-998.
10. Schreiber S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 287:2000;1964-1969.
11. Clark D.E., Pickett S.D. Computational methods for the prediction of drug-likeness. Drug Discov. Today. 5:2000;49-58.
12. Gentry, A.H. (1993) Tropical forest biodiversity and the potential for new medicinal plants. ACS Symposium Series Washington, DC American Chemical Society 534, 13-20.
13. Mendelson R., Balick M.J. The value of undiscovered pharmaceuticals in tropical forests. Econ. Bot. 49:1995;223-228.
14. Shu Y-Z. Recent natural products based drug development: A pharmaceutical industry perspective. J. Nat. Prod. 61:1998;1053-1071.
15. Bolten B.M., De Gregorio T. Trends in development cycle. Nat. Rev. 1:2002;335-336.
16. Ebel J., Cosio E.G. Elicitors of plant defense responses. Int. Rev. Cytol. 148:1994;1-36.
17. Facchini P.J. Alkaloid biosynthesis in plants: biochemistry, cell biology, molecular regulation, and metabolic engineering applications. Annu. Rev. Plant Physiol. Plant Mol. Biol. 52:2001;29-66.
18. Dixon R.A., Paiva N.L. Stress-induced phenylpropanoid metabolism. Plant Cell. 7:1995;1085-1097.
19. Trapp S., Croteau R. Defensive resin biosynthesis in conifers. Annu. Rev. Plant Physiol. Plant Mol. Biol. 52:2001;689-724.
20. Turlings T.C.J., Tumlinson J.H. Systemic release of chemical signals by herbivore-injured corn. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8399-8402.
21. Darvill A.G., Albersheim P. Phytoalexins and their elicitors - a defense against microbial infection in plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 35:1984;243-275.
22. Dixon R.A. The phytoalexin response: Elicitation, signaling, and control of host gene expression. Biol. Rev. 61:1986;239-291.
23. Balandrin, M.F. et al. (1993) Plant-derived natural products in drug discovery and development: An overview. Acs Symposium Series Washington, D.C.: American Chemical Society 534, 2-12
24. Kibertis P., Roberts L. It's not just the genes. Science. 296:2002;685.
25. Hsiang P., Lewis K. Synergy in medicinal plants: anitimicrobials potentiated by multidrug pump inhibitors. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1433-1437.
26. Tao X., et al. A Phase I study of ethyl acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii Hook F in rheumatoid arthritis. J. Rheumatol. 28:2001;2160-2167.
27. Tao X., et al. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. Arthritis Rheum. 46:2002;1735-1743.
28. Su D., et al. Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii. Chin. J. Mod. Dev. Trad. Med. 10:1990;144-146.
29. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (2000) Guidance for Industry Botanical Drug Products. Online: http://www.fda.gov/cder/guidance/1221dft.htm#P131_3293
30. Glaser V. Billion-dollar market blossoms as botanicals take root. Nat. Biotechnol. 17:1999;17-18.
31. Venter J.C., et al. The sequence of human genome. Science. 291:2001;1304-1351.
32. Osowski S., et al. Pharmaceutical comparability of different therapeutic Echinacea preparations. Res. Compl. Nat. Classical Med. 7:2000;294-300.
33. Kressmann S., et al. Pharmaceutical quality of different Ginkgo biloba brands. J. Pharm. Pharmacol. 54:2002;661-669.
34. Izzo A.A., Ernst E. Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs. 61:2001;2163-2175.
35. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann. Intern. Med. 136:2002;42-53.
36. Kroll D.J. Concerns and needs for research in herbal supplement pharmacotherapy and safety. J. Herbal Pharmacother. 1:2001;3-23.
37. Potrykus I. Golden rice and beyond. Plant Physiol. 125:2001;1157-1161.
38. Ye X., et al. Engineering provitamin A (β-carotene) biosynthetic pathway into (caroteneoid-free) rice endosperm. Science. 287:2000;303-305.
39. Daniell H., et al. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6:2001;219-226.
40. Walmsley A.M., Arntzen C.J. Plants for delivery of edible vaccines. Curr. Opin. Biotechnol. 11:2000;126-129.
41. Bonetta L. Edible vaccines: Not quite ready for prime time. Nat. Med. 8:2002;95.
42. Thelen J.J., Ohlrogge J.B. Metabolic engineering of fatty acid biosynthesis in plants. Metab. Eng. 4:2002;12-21.
43. Liu, K. (2001) Modifying soybean oil through plant breeding and genetic engineering. In Proceedings of the World Conference on Oilseed Processing Utilization, Cancun, Mexico, 12-17 November 2000, pp. 84-89.
44. Webster D.E., et al. Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine. J. Virol. 76:2002;7910-7912.
45. Kong Q., et al. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. U. S. A. 98:2002;11539-11544.
46. Hu F.B., et al. Types of dietary fat and risk of coronary heart disease: A critical review. J. Am. Coll. Nutr. 20:2001;5-19.
47. Shintani D., DellaPenna D. Elevating the vitamin E content of plants through metabolic engineering. Science. 282:1998;2098-2100.
48. Frusciante L., et al. Evaluation and use of plant biodiversity for food and pharmaceuticals. Fitoterapia. 71:(Suppl. 1):2000;S66-S72.
49. Barber N.J., Barber J. Lycopene and prostate cancer. Prostate Cancer Prostatic Dis. 5:2002;6-12.
50. Forkmann G., Martens S. Metabolic engineering and applications of flavonoids. Curr. Opin. Biotechnol. 12:2001;155-160.
51. Muir S.R., et al. Overexpression of petunia chalcone isomerase in tomato results in fruits containing increased levels of flavonols. Nat. Biotechnol. 19:2001;470-474.
52. Buchanan B.B., et al. Thioredoxin-linked mitigation of allergic responses to wheat. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5372-5377.
53. Garber K. Biotech industry faces new bottleneck. Nat. Biotechnol. 19:2001;184-185.
54. During, K. (1988) Wundinduzierbare Expression und Sekretion von T4 Lysozym und Monoklonalen Antikorpern in Nicotiana tabacum. Doctoral Dissertation, University of Koln, Germany
55. Hiatt A., et al. Production of antibodies in transgenic plants. Nature. 342:1989;76-78.
56. Fischer R., Emans N. Molecular pharming of pharmaceutical proteins. Transgenic Res. 9:2000;279-299.
57. Giddings G., et al. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18:2000;1151-1155.
58. Daniell H. Medical molecular pharming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Biol. 6:2001;219-226.
59. Conrad U., Fiedler U. Compartment-specific accumulation of recombinant immunoglobulins in plant cells: An essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol. Biol. 38:1998;101-109.
60. Firek S., et al. Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures. Plant Mol. Biol. 23:1993;861-870.
61. Parmenter D.L., et al. Production of biologically active hirudin in plant seeds using oleosin partitioning. Plant Mol. Biol. 29:1995;1167-1180.
62. Borisjuk N.V., et al. Production of recombinant proteins in plant root exudates. Nat. Biotechnol. 17:1999;466-469.
63. Komarnytsky S., et al. Production of recombinant proteins in tobacco guttation fluid. Plant Physiol. 124:2000;927-933.
64. Hodgson J. Expression systems: A user's guide. Emphasis has shifted from the vector construct to the host organism. Biotechnology. 11:1993;887-893.
65. Mason H.S., et al. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11745-11749.
66. Ruggiero F., et al. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett. 469:2000;132-136.
67. Ramirez N., et al. Expression of a single-chain Fv antibody fragment specific for the hepatitis B surface antigen in transgenic tobacco plants. Transgenic Res. 11:2002;61-64.
68. Frigerio L., et al. Assembly, secretion, and vacuolar delivery of a hybrid immunoglobulin in plants. Plant Physiol. 123:2000;1483-1494.
69. Schouten A., et al. The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol. Biol. 30:1996;781-793.
70. Torres E., et al. Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res. 8:1999;441-449.
71. Fiedler U., et al. Optimization of scFv antibody production in transgenic plants. Immunotechnology. 3:1997;205-216.
72. Ma J.K., et al. Generation and assembly of secretory antibodies in plants. Science. 268:1995;716-719.
73. De Wilde C., et al. Intact antigen-binding MAK33 antibody and Fab fragment accumulate in intercellular spacers of Arabidopsis thaliana. Plant Sci. 114:1996;233-241.
74. Hood E.E., et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol. Breed. 3:1997;291-306.
75. Artsaenko O., et al. Potato tubers as a biofactory for recombinant antibodies. Mol. Breed. 4:1998;313-319.
76. Baum T.J., et al. Expression in tobacco of a functional monoclonal antibody specific to stylet secretions of the root-knot nematode. Mol. Plant Microbe Interact. 9:1996;382-387.
77. Sandhu J.S., et al. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res. 9:2000;127-135.
78. Staub J.M., et al. High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. 18:2000;333-338.
79. Kumagai M.H., et al. Rapid, high-level expression of biologically active alpha-trichosanthin in transfected plants by an RNA viral vector. Proc. Natl. Acad. U. S. A. 90:1993;427-430.